Previous Close | 42.33 |
Open | 42.76 |
Bid | 41.95 x 800 |
Ask | 43.66 x 900 |
Day's Range | 42.56 - 42.90 |
52 Week Range | 39.03 - 47.44 |
Volume | |
Avg. Volume | 1,188,137 |
Market Cap | 9.508B |
Beta (5Y Monthly) | 0.40 |
PE Ratio (TTM) | 97.23 |
EPS (TTM) | 0.44 |
Earnings Date | Feb 07, 2025 - Feb 11, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jan 30, 2024 |
1y Target Est | 50.59 |
To support internal growth, QGEN heavily invests in R&D for the menu expansion of its key platforms.
Investors feel optimistic about QGEN's growth prospects in the NGS platforms. Yet, an unfavorable currency impact on the company's operations is concerning.